IMUGENE CHART. TA only, page-7226

That's what the chart is telling us, a SP of almost $3 by the end of the next year but that is based on SP movement trend since March 2020 until now.
Will the trend continue or progress faster or slower? I don't know.

There are going to be things that influence the SP such as:
- the expected time it takes for trials to be successfully completed and
- the time it takes to for the vaccines to be approved for public use and
- no failures, no delays in trials, no delays in approvals etc etc
- market sentiment

What significance the above have for the SP to reach $3, and the $ effect of each, I don't know.
There are many more years for this to play out to an even greater share price - all going well.